Literature DB >> 33266329

Left Ventricular Mass Reduction by a Low-Sodium Diet in Treated Hypertensive Patients.

Natale Musso1, Federico Gatto1, Federica Nista1, Andrea Dotto1, Zhongyi Shen1, Diego Ferone1.   

Abstract

OBJECTIVE: To evaluate the left ventricular mass (LVM) reduction induced by dietary sodium restriction. PATIENTS AND METHODS: A simple sodium-restricted diet was advised in 138 treated hypertensives. They had to avoid common salt loads, such as cheese and salt-preserved meat, and were switched from regular to salt-free bread. Blood pressure (BP), 24-h urinary sodium (UNaV) and LVM were recorded at baseline, after 2 months. and after 2years.
RESULTS: In 76 patients UNaV decreased in the recommended range after 2 months and remained low at 2 years. In 62 patients UNaV levels decreased after 2 months and then increased back to baseline at 2 years. Initially the two groups did not differ in terms of BP (134.3 ± 16.10 / 80.84 ± 12.23 vs.134.2 ± 16.67 / 81.55 ± 11.18 mmHg, mean ± SD), body weight (72.64 ± 15.17 vs.73.79 ± 12.69 kg), UNaV (161.0 ± 42.22 vs.158.2 ± 48.66 mEq/24 h), and LVM index (LVMI; 97.09 ± 20.42 vs.97.31 ± 18.91 g/m2). After 2years. they did not differ in terms of BP (125.3 ± 10.69 / 74.97 ± 7.67 vs.124.5 ± 9.95 / 75.21 ± 7.64 mmHg) and body weight (71.14 ± 14.29 vs.71.50 ± 11.87 kg). Significant differences were seen for UNaV (97.3 ± 23.01 vs.152.6 ± 49.96 mEq/24 h) and LVMI (86.38 ± 18.17 vs.103.1 ± 21.06 g/m2). Multiple regression analysis: UNaV directly and independently predicted LVMI variations, either as absolute values (R2 = 0.369; β = 0.611; p < 0.001), or changes from baseline to +2years. (R2 = 0.454; β = 0.677; p < 0.001). Systolic BP was a weaker predictor of LVMI (R2 = 0.369; β = 0.168; p = 0.027; R2 = 0.454; β = 0.012; p = 0.890), whereas diastolic BP was not correlated with LVMI. The prevalence of left ventricular hypertrophy decreased (29/76 to 15/76) in the first group while it increased in the less compliant patients (25/62 to 36/62; Chi2p = 0.002).
CONCLUSION: LVM seems linked to sodium consumption in patients already under proper BP control by medications.

Entities:  

Keywords:  blood pressure; hypertension; left ventricular hypertrophy; left ventricular mass; low-sodium diet; sodium consumption

Mesh:

Substances:

Year:  2020        PMID: 33266329      PMCID: PMC7761364          DOI: 10.3390/nu12123714

Source DB:  PubMed          Journal:  Nutrients        ISSN: 2072-6643            Impact factor:   5.717


  53 in total

1.  A formula to estimate the approximate surface area if height and weight be known. 1916.

Authors:  D Du Bois; E F Du Bois
Journal:  Nutrition       Date:  1989 Sep-Oct       Impact factor: 4.008

Review 2.  Changes in left ventricular geometry during antihypertensive treatment.

Authors:  Massimo Salvetti; Anna Paini; Fabio Bertacchini; Deborah Stassaldi; Carlo Aggiusti; Claudia Agabiti Rosei; Davide Bassetti; Enrico Agabiti-Rosei; Maria Lorenza Muiesan
Journal:  Pharmacol Res       Date:  2018-06-26       Impact factor: 7.658

3.  Echocardiographic assessment of left ventricular hypertrophy: comparison to necropsy findings.

Authors:  R B Devereux; D R Alonso; E M Lutas; G J Gottlieb; E Campo; I Sachs; N Reichek
Journal:  Am J Cardiol       Date:  1986-02-15       Impact factor: 2.778

4.  Salt intake during pregnancy alters offspring's myocardial structure.

Authors:  E N Alves-Rodrigues; M M Veras; K T Rosa; I de Castro; L N S Furukawa; I B Oliveira; R M Souza; J C Heimann
Journal:  Nutr Metab Cardiovasc Dis       Date:  2012-03-06       Impact factor: 4.222

5.  High salt-induced hypertrophy of human vascular smooth muscle cells associated with a decrease in glycocalyx.

Authors:  Ghassan Bkaily; Yanick Simon; Istok Menkovic; Carl Bkaily; Danielle Jacques
Journal:  J Mol Cell Cardiol       Date:  2018-10-12       Impact factor: 5.000

6.  Dietary sodium and target organ damage in essential hypertension.

Authors:  Guilhem du Cailar; Jean Ribstein; Albert Mimran
Journal:  Am J Hypertens       Date:  2002-03       Impact factor: 2.689

7.  Effects on left ventricular hypertrophy of long-term nonpharmacological treatment with sodium restriction in mild-to-moderate essential hypertension.

Authors:  A M Jula; H M Karanko
Journal:  Circulation       Date:  1994-03       Impact factor: 29.690

Review 8.  Associations of urinary sodium excretion with cardiovascular events in individuals with and without hypertension: a pooled analysis of data from four studies.

Authors:  Andrew Mente; Martin O'Donnell; Sumathy Rangarajan; Gilles Dagenais; Scott Lear; Matthew McQueen; Rafael Diaz; Alvaro Avezum; Patricio Lopez-Jaramillo; Fernando Lanas; Wei Li; Yin Lu; Sun Yi; Lei Rensheng; Romaina Iqbal; Prem Mony; Rita Yusuf; Khalid Yusoff; Andrzej Szuba; Aytekin Oguz; Annika Rosengren; Ahmad Bahonar; Afzalhussein Yusufali; Aletta Elisabeth Schutte; Jephat Chifamba; Johannes F E Mann; Sonia S Anand; Koon Teo; S Yusuf
Journal:  Lancet       Date:  2016-05-20       Impact factor: 79.321

Review 9.  Sodium and Its Role in Cardiovascular Disease - The Debate Continues.

Authors:  Yee Wen Kong; Sara Baqar; George Jerums; Elif I Ekinci
Journal:  Front Endocrinol (Lausanne)       Date:  2016-12-23       Impact factor: 5.555

10.  Association of Estimated Sodium Intake With Adverse Cardiac Structure and Function: From the HyperGEN Study.

Authors:  Senthil Selvaraj; Luc Djoussé; Frank G Aguilar; Eva E Martinez; Vincenzo B Polsinelli; Marguerite R Irvin; Donna K Arnett; Sanjiv J Shah
Journal:  J Am Coll Cardiol       Date:  2017-08-08       Impact factor: 24.094

View more
  1 in total

1.  Association of Urinary Sodium Excretion and Left Ventricular Hypertrophy in People With Type 2 Diabetes Mellitus: A Cross-Sectional Study.

Authors:  Jianfang Liu; Xiaoyu Yang; Peizhen Zhang; Dan Guo; Bingyan Xu; Chensihan Huang; Yaoming Xue; Huijie Zhang
Journal:  Front Endocrinol (Lausanne)       Date:  2021-09-28       Impact factor: 5.555

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.